[Skip to Content]
[Skip to Content Landing]
Views 412
Citations 0
Invited Commentary
March 5, 2020

Further Considerations About the Ophthalmic Sequelae of Ebola

Author Affiliations
  • 1Center for Global and Immigrant Health, Department of Epidemiology, UCLA Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, Los Angeles
  • 2The University of California, Los Angeles–Democratic Republic of Congo Health Research and Training Program, Kinshasa, Democratic Republic of Congo
  • 3Ocular Inflammatory Disease Center, UCLA Stein Eye Institute, David Geffen School of Medicine at UCLA, Los Angeles, California
  • 4Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California
JAMA Ophthalmol. 2020;138(4):403-404. doi:10.1001/jamaophthalmol.2020.0185

In this issue of JAMA Ophthalmology, Steptoe and associates present another in their series of articles dealing with ocular lesions found in survivors of the 2013-2016 outbreak of Ebola virus disease (EVD) in West Africa.1 They describe fundus changes that had occurred over a 1-year period among a cohort of 57 survivors of EVD whose median posthospitalization interval was slightly more than 2 years. This article expands on their June 2018 article2 about selected individuals from their primary cohort of 82 survivors of EVD; we also provided commentary about that article.3 Ebola virus disease has continued to be a major public health problem since those articles were published.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×